Abdominal Wall "Closure".
2015Hernia : the journal of hernias and abdominal wall surgery
Harlaar J, Deerenberg EB, Dwarkasing RS, Kamperman AM, Jeekel J +46 more
PubMedWILMINGTON, NC
Dr. Kotwall studies different types of cancer and their treatments, particularly focusing on thyroid cancer, breast cancer, and soft tissue sarcomas. He explores the effectiveness of surgeries, such as breast-conserving procedures, and treatments like the topical cream imiquimod for skin cancers. His research also addresses the complexities of early-stage breast cancer management and the implications of surgical margins on cancer recurrence. Additionally, he investigates the long-term outcomes for patients with challenging cancers, such as retroperitoneal soft tissue sarcomas and squamous cell cancers in the head and neck region.
Hernia : the journal of hernias and abdominal wall surgery
Harlaar J, Deerenberg EB, Dwarkasing RS, Kamperman AM, Jeekel J +46 more
PubMedThyroid : official journal of the American Thyroid Association
Bohinc BN, Parker JC, Hope WW, Kotwall C, Turner J +2 more
Plain English
This study looked at a rare case of ectopic thyroid tissue found in the adrenal gland of a 61-year-old woman who also had a small thyroid cancer. The researchers were uncertain whether the thyroid tissue in the adrenal gland was a spread of cancer from the thyroid or a separate benign tissue growth, which affects how the patient should be treated. They found that while many small thyroid cancers do not spread, some can, and they emphasized the need for better tests to figure out which tumors are likely to be aggressive.
Who this helps: This helps doctors make better treatment decisions for patients with thyroid-related issues.
The American surgeon
Kotwall C, Ranson M, Stiles A, Hamann MS
Plain English
This study looked at how the initial results of surgical biopsies for breast cancer relate to whether any cancer remains after a second surgery. Researchers reviewed the cases of 582 women and found that patients with very close (less than 1mm) or mixed margins had higher chances of remaining cancer after re-surgery, with 30% of those with the worst margins still having invasive cancer. This matters because it can help doctors decide when to perform additional surgeries to ensure all cancer is removed.
Who this helps: This helps patients with early-stage invasive breast cancer.
The American surgeon
McCutcheon B, White K, Kotwall C, Germolic D, Rebolloso Y +2 more
Plain English
This study looked at the effects of a cream called imiquimod on different types of basal cell carcinoma, a common skin cancer. Out of 10 patients treated, 9 had their cancer patches disappear after using the cream for three weeks. The study also noted that a specific immune reaction marker, IL-8, went down by about 44%, suggesting that imiquimod might work by affecting this marker.
Who this helps: This benefits patients with various types of basal cell carcinoma, offering a potential treatment option.
American journal of surgery
Kotwall C, Brinker C, Covington D, Hall T, Hamann MS +3 more
Plain English
This study looked at how surgery for ductal carcinoma in situ (DCIS), a common form of breast cancer, has changed over the past decade. Researchers found that at their hospital, the use of breast-conserving surgery (BCS) increased steadily, particularly among younger women and those with private insurance, while nationally only 20% of patients got BCS, and that rate didn’t improve over 12 years. This is important because it highlights the need for better education about treatment options for older women and surgeons, so more patients can benefit from less invasive surgeries.
Who this helps: Patients, especially younger women and those with DCIS.
Journal of surgical oncology
Lewis SJ, Wunder JS, Couture J, Davis M, Catton C +4 more
Plain English
This study examined 18 patients with rare tumors called soft tissue sarcomas in the pelvis to understand how the tumors spread and how they were treated. The researchers found that 11 out of 18 patients died on average 15.5 months after surgery, highlighting the challenges of effectively treating these tumors. This matters because it helps doctors better plan surgeries and understand the likely outcomes for patients undergoing treatment for these difficult-to-manage cancers.
Who this helps: This helps patients and their doctors understand treatment options and the risks involved with pelvic soft tissue sarcomas.
American journal of surgery
Kotwall C, Covington D, Churchill P, Brinker C, Weintritt D +1 more
Plain English
This study looked at the use of breast conservation surgery (BCS) for women with breast cancer at a regional medical center from 1990 to 1996, involving 634 patients. The researchers found that the percentage of women receiving BCS increased from 17% in 1990 to 41% in 1996. Factors that made women more likely to have BCS included having smaller tumors, being younger than 50, having certain types of insurance, and being treated by more recently trained surgeons.
Who this helps: This benefits women with early-stage breast cancer who are exploring treatment options.
International journal of radiation oncology, biology, physics
Catton CN, O'Sullivan B, Kotwall C, Cummings B, Hao Y +1 more
Plain English
This study looked at the outcomes of treatment for 104 patients with a type of cancer called retroperitoneal soft tissue sarcoma. The researchers found that only 36% of patients survived for 5 years, and just 14% survived for 10 years. Successful removal of the tumor through surgery was the most important factor for improving survival rates, especially for those who underwent complete surgery followed by radiation therapy, which extended the time before the cancer returned.
Who this helps: This helps patients with retroperitoneal soft tissue sarcoma and their doctors in understanding treatment options and outcomes.
Canadian journal of surgery. Journal canadien de chirurgie
Kotwall C, Williams HT
Plain English
This study looked at 185 patients who had surgery to treat duodenal ulcers, specifically focusing on a procedure called vagotomy combined with antrectomy. The researchers found that there were very few complications: only one patient died during their hospital stay, and about 11% had some early issues, with 2 patients developing a recurring ulcer over an average follow-up of 13.5 years. These results show that this surgery is still a safe and effective option for treating duodenal ulcers, especially compared to other methods that have higher rates of recurrence.
Who this helps: This benefits patients suffering from duodenal ulcers, as well as the doctors who treat them.
Journal of surgical oncology
Kotwall C, Razack MS, Sako K, Rao U
Plain English
This study looked at 832 patients who had squamous cell cancer of the head and neck, focusing on how often they developed additional cancers. Researchers found that, per year, about 4.04% of these patients went on to develop a second primary cancer in areas like the head and neck, lung, or esophagus before they passed away. This is important because it highlights a significant risk for patients with this type of cancer, indicating they need careful monitoring for other cancers.
Who this helps: Patients with squamous cell cancer of the head and neck.
American journal of surgery
Kotwall C, Sako K, Razack MS, Rao U, Bakamjian V +1 more
Plain English
This study looked at 832 patients with head and neck squamous cell cancer who died between 1961 and 1985 to understand how often and where their cancer spread. They found that nearly half (47%) of these patients had distant metastases, with the highest rates in those with cancer in the hypopharynx (60%) and advanced stage IV disease (55%). Most distant spread occurred in the lungs (80%), and a significant number of patients (91%) died with uncontrolled tumors.
Who this helps: This research benefits doctors and patients by highlighting the aggressive nature of certain head and neck cancers and the importance of early detection and treatment.
Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.